RIZVIIMI

Serial Number 99107336
686

Registration Progress

Application Filed
Mar 27, 2025
Under Examination
Approved for Publication
Nov 4, 2025
Published for Opposition
Nov 4, 2025
Registered

Attorney Assistance

Published for Opposition
Due: Dec 04, 2025 25 days

Trademark Image

RIZVIIMI

Basic Information

Serial Number
99107336
Filing Date
March 27, 2025
Published for Opposition
November 4, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
686
Status Date
Nov 4, 2025
Application
Pending
Classes
005

Rights Holder

Glaxo Group Limited

99
Address
GSK Medicines Research Centre
Gunnels Wood Road
Stevenage SG12NY
GB

Ownership History

Glaxo Group Limited

Original Applicant
99
Stevenage GB

Glaxo Group Limited

Owner at Publication
99
Stevenage GB

Legal Representation

Attorney
Christopher M. Hanes

USPTO Deadlines

Next Deadline
25 days remaining
Published for Opposition
Due Date
December 04, 2025
Extension Available
Until January 04, 2026

Application History

14 events
Date Code Type Description Documents
Nov 4, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Nov 4, 2025 PUBO A PUBLISHED FOR OPPOSITION Loading...
Oct 29, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Oct 1, 2025 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Sep 11, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Sep 11, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Sep 11, 2025 ERSI I TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Loading...
Aug 28, 2025 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Loading...
Aug 28, 2025 GNSL F LETTER OF SUSPENSION E-MAILED Loading...
Aug 28, 2025 CNSL R SUSPENSION LETTER WRITTEN Loading...
Aug 26, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
Mar 27, 2025 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Mar 27, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Mar 27, 2025 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Vaccines; Anti-infectives; Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders; Pharmaceutical preparations for the prevention of infectious diseases

Classification

International Classes
005